Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 14Neoplasms 7Endometrial Neoplasms 6Lung Neoplasms 5Melanoma 4Head and Neck Neoplasms 4Colonic Neoplasms 4Esophageal Neoplasms 3Uterine Cervical Neoplasms 2Solitary Pulmonary Nodule 2Multiple Pulmonary Nodules 2Lymphedema 2Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Brain Neoplasms 2Vulvar Neoplasms 1Uterine Neoplasms 1Thyroid Neoplasms 1Suspected Central Nervous System Tumors 1Stomach Neoplasms 1Skull Base Neoplasms 1Skin Neoplasms 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Peritoneal Neoplasms 1Pediatric Patients With Solid Tumors 1

Interventions

Uterine Artery Embolization 2Saline Solution 1Indocyanine Green 1Ibuprofen 1High-Energy Shock Waves 1Gonadotropin-Releasing Hormone 1Elasticity Imaging Techniques 1Dexamethasone 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Adenomyosis × Indocyanine Green × Clear all
NCT03927651 2023-04-18

ICG to Assess Ovarian Perfusion

Northwestern University

Phase EARLY_PHASE1 Completed
54 enrolled

Endometriosis, Leiomyoma, Myofibroma, Adenomyosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡